These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 34845270)

  • 41. In vitro folding and thermodynamic stability of an antibody fragment selected in vivo for high expression levels in Escherichia coli cytoplasm.
    Martineau P; Betton JM
    J Mol Biol; 1999 Oct; 292(4):921-9. PubMed ID: 10525415
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Production and applications of fluorobody from redox-engineered Escherichia coli.
    Srila W; Min TT; Sumphanapai T; Rangnoi K; Berkmen M; Yamabhai M
    Appl Microbiol Biotechnol; 2023 Mar; 107(5-6):1959-1970. PubMed ID: 36729226
    [TBL] [Abstract][Full Text] [Related]  

  • 43. High-level expression and characterization of an anti-VEGF165 single-chain variable fragment (scFv) by small ubiquitin-related modifier fusion in Escherichia coli.
    Ye T; Lin Z; Lei H
    Appl Microbiol Biotechnol; 2008 Nov; 81(2):311-7. PubMed ID: 18795288
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Anti-HER2 scFv Expression in Escherichia coli SHuffle
    Ahmadzadeh M; Farshdari F; Nematollahi L; Behdani M; Mohit E
    Mol Biotechnol; 2020 Jan; 62(1):18-30. PubMed ID: 31691197
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Construction and bacterial expression of a recombinant single-chain antibody fragment against Wuchereria bancrofti SXP-1 antigen for the diagnosis of lymphatic filariasis.
    Kamatchi R; Charumathi J; Ravishankaran R; Kaliraj P; Meenakshisundaram S
    J Helminthol; 2016 Jan; 90(1):74-80. PubMed ID: 26693887
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Preparation of single-chain Fv antibodies in the cytoplasm of Escherichia coli by simplified and systematic chaperone optimization.
    Liu C; Kobashigawa Y; Yamauchi S; Toyota Y; Teramoto M; Ikeguchi Y; Fukuda N; Sato T; Sato Y; Kimura H; Morioka H
    J Biochem; 2019 Dec; 166(6):455-462. PubMed ID: 31755921
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Gateway vectors for the production of combinatorially-tagged His6-MBP fusion proteins in the cytoplasm and periplasm of Escherichia coli.
    Nallamsetty S; Austin BP; Penrose KJ; Waugh DS
    Protein Sci; 2005 Dec; 14(12):2964-71. PubMed ID: 16322578
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A novel protein fusion partner, carbohydrate-binding module family 66, to enhance heterologous protein expression in Escherichia coli.
    Ko H; Kang M; Kim MJ; Yi J; Kang J; Bae JH; Sohn JH; Sung BH
    Microb Cell Fact; 2021 Dec; 20(1):232. PubMed ID: 34963459
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Design and Generation of Humanized Single-chain Fv Derived from Mouse Hybridoma for Potential Targeting Application.
    Khantasup K; Chantima W; Sangma C; Poomputsa K; Dharakul T
    Monoclon Antib Immunodiagn Immunother; 2015 Dec; 34(6):404-17. PubMed ID: 26683180
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Redesigning of anti-c-Met single chain Fv antibody for the cytoplasmic folding and its structural analysis.
    Edwardraja S; Neelamegam R; Ramadoss V; Venkatesan S; Lee SG
    Biotechnol Bioeng; 2010 Jun; 106(3):367-75. PubMed ID: 20178123
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A His6-SUMO-eXact tag for producing human prepro-urocortin 2 in Escherichia coli for raising monoclonal antibodies.
    Liew OW; Ang CX; Peh YP; Chong PC; Ng YX; Hwang LA; Koh XY; Yip YM; Liu W; Richards AM
    J Immunol Methods; 2014 Jan; 403(1-2):37-51. PubMed ID: 24291344
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Soluble production of a biologically active single-chain antibody against murine PD-L1 in Escherichia coli.
    Drees JJ; Augustin LB; Mertensotto MJ; Schottel JL; Leonard AS; Saltzman DA
    Protein Expr Purif; 2014 Feb; 94():60-6. PubMed ID: 24215864
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Extracellular production of functional single-chain variable fragment against aflatoxin B
    Na KI; Kim SJ; Choi DS; Min WK; Kim SG; Seo JH
    Lett Appl Microbiol; 2019 Mar; 68(3):241-247. PubMed ID: 30584665
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Production in yeast of pseudotype virus-like particles harboring functionally active antibody fragments neutralizing the cytolytic activity of vaginolysin.
    Pleckaityte M; Zvirbliene A; Sezaite I; Gedvilaite A
    Microb Cell Fact; 2011 Dec; 10():109. PubMed ID: 22171920
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of cytoplasmic and periplasmic chaperones on secretory production of single-chain Fv antibody in Escherichia coli.
    Sonoda H; Kumada Y; Katsuda T; Yamaji H
    J Biosci Bioeng; 2011 Apr; 111(4):465-70. PubMed ID: 21324738
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Optimization of culture conditions for the expression of three different insoluble proteins in Escherichia coli.
    Gutiérrez-González M; Farías C; Tello S; Pérez-Etcheverry D; Romero A; Zúñiga R; Ribeiro CH; Lorenzo-Ferreiro C; Molina MC
    Sci Rep; 2019 Nov; 9(1):16850. PubMed ID: 31727948
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Antigenic epitopes on the outer membrane protein A of Escherichia coli identified with single-chain variable fragment (scFv) antibodies.
    Mwale PF; Lee CH; Leu SJ; Lee YC; Wu HH; Lin LT; Lin TE; Huang YJ; Yang YY
    Appl Microbiol Biotechnol; 2019 Jul; 103(13):5285-5299. PubMed ID: 31028439
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Preparation and characterization of recombinant protein ScFv(CD11c)-TRP2 for tumor therapy from inclusion bodies in Escherichia coli.
    Kou G; Shi S; Wang H; Tan M; Xue J; Zhang D; Hou S; Qian W; Wang S; Dai J; Li B; Guo Y
    Protein Expr Purif; 2007 Mar; 52(1):131-8. PubMed ID: 17027283
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Overproduction of anti-Tn antibody MLS128 single-chain Fv fragment in Escherichia coli cytoplasm using a novel pCold-PDI vector.
    Subedi GP; Satoh T; Hanashima S; Ikeda A; Nakada H; Sato R; Mizuno M; Yuasa N; Fujita-Yamaguchi Y; Yamaguchi Y
    Protein Expr Purif; 2012 Mar; 82(1):197-204. PubMed ID: 22245752
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Characterization of a single chain variable fragment of nivolumab that targets PD-1 and blocks PD-L1 binding.
    Shin J; Phelan PJ; Gjoerup O; Bachovchin W; Bullock PA
    Protein Expr Purif; 2021 Jan; 177():105766. PubMed ID: 32987122
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.